Preliminary results of a phase II clinical trial of Genz-112638 in patients with type I Gaucher disease

被引：1

作者：

Peterschmitt, Judith ^{[1
,8
]}

Lukina, Elena ^{[2
,8
]}

Watman, Nora ^{[3
,8
]}

Banikazemi, Maryam ^{[4
,8
]}

Iastrebner, Marcelo ^{[5
,8
]}

Rosenbaum, Hanna ^{[6
,8
]}

Zimran, Ari ^{[7
,8
]}

Arreguin, Elsa Avila ^{[7
,8
]}

O'Brien, Fanny ^{[1
,8
]}

Smith, Sharon ^{[1
,8
]}

Puga, Ana Cristina ^{[1
,8
]}

机构：

[1] Genzyme Corp, Cambridge, MA USA

[2] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia

[3] Hosp Ramos Mejia, Buenos Aires, DF, Argentina

[4] NYU, New York, NY USA

[5] Inst Argentino Diagnost & Tratamiento, Buenos Aires, DF, Argentina

[6] Rambam Med Ctr, Haifa, Israel

[7] Shaare Zedek Med Ctr, Jerusalem, Israel

[8] Seguro Social Hosp Especialidades, Inst Mexicano, Col La Raza, Mexico

来源：

MOLECULAR GENETICS AND METABOLISM | 2008年 / 93卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2007.10.085

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S32 / S33

页数：2

共 50 条

[41] Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat
Ravi S. Kamath
Elena Lukina
Nora Watman
Marta Dragosky
Gregory M. Pastores
Elsa Avila Arreguin
Hanna Rosenbaum
Ari Zimran
Rasha Aguzzi
Ana Cristina Puga
Andrea M. Norfleet
M. Judith Peterschmitt
Daniel I. Rosenthal
Skeletal Radiology, 2014, 43 : 1353 - 1360
[42] PRELIMINARY RESULTS OF THE PHASE I/II RELEASE CLINICAL TRIAL WITH ADOPTIVE CELL THERAPY WITH MEMORY T-LYMPHOCYTES FOR PATIENTS WITH MODERATE/SEVERE COVID19 DISEASE
Martinez Antonio, Perez
Puente Cristina, Ferreras
Quiros Alejandro, Martin
Sanz Karima, Al-Kaoui
Garcia Pilar, Guerra
Miguel Barbara, Pascual
Duran Carmen, Mestre
Alberto, Borobia
Parada Javier, Queiruga
Irene, Garcia
Rillo Marta, Mora
Zapardie Elena, Sanchez
Mercedes, Gasior
Raquel, De Paz
Antonio, Marcos
Jose Luis, Vicario
Antonio, Balas
Cristina, Eguizabal
Carlos, Solano
Jose Ramon, Arribas
Bernat, Soria
HAEMATOLOGICA, 2021, 106 (10) : 128 - 128
[43] STREAMS: PRELIMINARY RESULTS FROM A PHASE II TRIAL
Ali, Rehiana
Nicolas, Richard
Marley, Stephen
Palanicawandar, Renuka
Dazzi, Francesco
Muraro, Paolo
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
[44] PRELIMINARY-RESULTS OF A PHASE-I TRIAL
BRETEAU, N
SABATTIER, R
FAVRE, A
DESTEMBERT, B
BULLETIN DU CANCER, 1983, 70 (03) : 229 - 229
[45] Phase I/II, nine month study results of enzyme replacement therapy with gene activated human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease.
Mensah, R
Elstein, D
BLOOD, 2005, 106 (11) : 51B - 51B
[46] Phase II clinical trial results of chaperonin 10 in patients with RA
Nature Clinical Practice Rheumatology, 2006, 2 (12): : 641 - 642
[47] Oxidative stress parameters of Gaucher disease type I patients
Mello, Alexandre Silva
Garcia, Cristina Da Silva
Machado, Fernanda De Souza
Medeiros, Niara Da Silva
Wohlenberg, Mariane Farias
Marinho, Jessica Pereira
Dani, Caroline
Funchal, Claudia
Coelho, Janice Carneiro
MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 4 : 1 - 5
[48] Xenovaccination of patients with skin melanoma: phase I/II clinical trial
Moiseyenko, Vladimir
Baldueva, I.
Danilov, A.
Danilov, A.
TUMOR BIOLOGY, 2006, 27 : 44 - 44
[49] Phase I/II, 9-month study results of enzyme replacement therapy with Gene-Activated® human glucocerebrosidase in patients with type 1 Gaucher disease
Zimran, A.
Fratazzi, C.
Altarescu, G.
Mensah, R.
Elstein, D.
ACTA PAEDIATRICA, 2007, 96 : 106 - 106
[50] ENCAPSULATED ISLET TRANSPLANTATION IN TYPE-I DIABETES - PRELIMINARY-RESULTS OF PHASE-I/II CLINICAL-TRIALS
SOONSHIONG, P
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 5 - 5

← 1 2 3 4 5 →